JPRN-UMIN000020244已完成未知
The low-fluence Q-switched 1,064-nm neodymium:yttrium-aluminium-garnet laser for the treatment of pigmented lesion; Prospective, randomized, and split-face comparative study - The study of laser torning for the treatment of the pigmented lesion;
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •they have the severe disease
研究者
相似试验
已完成
不适用
A randomized, double-blind, placebo-controlled design phase 2 clinical trial to comparatively evaluate the efficacy and safety of CP-COV03 in patients with mild or moderate COVID-19Codes for special purposesKCT0007307Hyundai Bioscience300
进行中（未招募）
1 期
A placebo-controlled, proof-of concept study of the efficacy and safety of gevokizumab in the treatment of patients with giant cell arteritisGiant cell arteritisEUCTR2013-002778-38-ITInstitut de Recherches Internationales Servier (IRIS)50
进行中（未招募）
不适用
A placebo-controlled, proof-of concept study of the efficacy and safety of gevokizumab in the treatment of patients with giant cell arteritisGiant cell arteritisEUCTR2013-002778-38-EEInstitut de Recherches Internationales Servier (IRIS)50
进行中（未招募）
不适用
A placebo-controlled, proof-of concept study of the efficacy of gevokizumab subcutaneously over 24 weeks in the treatment of patients with polymyositis , dermatomyositis or necrotizing autoimmune myophaty diseasePolymyositis / Dermatomyositis /necrotizing autoimmune myophatyMedDRA version: 17.1Level: PTClassification code 10012503Term: DermatomyositisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 17.1Level: PTClassification code 10036102Term: PolymyositisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2012-005772-34-HUInstitut de Recherches Internationales Servier (IRIS)40
进行中（未招募）
不适用
A placebo-controlled, proof-of concept study of the efficacy of gevokizumab subcutaneously over 24 weeks in the treatment of patients with polymyositis, dermatomyositis or necrotizing autoimmune myopathy disease.Polymyositis / Dermatomyositis / necrotizing autoimmune myopathyMedDRA version: 17.1Level: PTClassification code 10012503Term: DermatomyositisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 17.1Level: PTClassification code 10036102Term: PolymyositisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2012-005772-34-SEInstitut de Recherches Internationales Servier (IRIS)40